Finance

Lists
Why is OBX up 10.95%?
Dive Deeper
OBX:NASDAQ
Obsidian Therapeutics, Inc
$13.58
+10.95%
(+1.34) 1D
Oct 9, 12:09:55 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBX...
Open
$12.25
High
$13.95
Low
$12.25
Mkt. cap
837.64M
Avg. vol.
562.80K
Volume
157.18K
P/E ratio
0.10
52-wk high
$49.97
52-wk low
$12.09
EPS
$131.43
No. of employees
87
Open
$12.25
High
$13.95
Low
$12.25
Mkt. cap
837.64M
Avg. vol.
562.80K
Volume
157.18K
P/E ratio
0.10
52-wk high
$49.97
52-wk low
$12.09
EPS
$131.43
No. of employees
87
News stories
From web sources and news partners
About Obsidian Therapeutics, Inc
CEO-
Employees87
Founded2015
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to OBX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OBX in the last 3 months.
Highest
Current $13.58
$43.00 (+216.64%)
Average
$40.00 (+194.55%)
Lowest
$32.00 (+135.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sam Slutsky
LifeSci Capital
Buy
Maintained
$43.00
+216.6%
09/29/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
$32.00
+135.6%
09/23/2026
Sami Corwin
William Blair
Buy
Initiated
$43.00
+216.6%
09/09/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
08/06/2026
Kelsey Goodwin
Piper Sandler
Buy
Initiated
$42.00
+209.3%
08/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.13M
22.95M
15.73M
21.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.48M
5.31M
4.55M
4.59M
Operating expense
26.60M
28.26M
20.28M
26.14M
Total operating expenses
26.60M
28.26M
20.28M
26.14M
Operating income
-26.60M
-28.26M
-20.28M
-26.14M
Other non operating income
-
-
-
-
EBT including unusual items
-24.99M
-26.90M
-19.63M
-25.86M
EBT excluding unusual items
-24.99M
-26.90M
-19.63M
-25.86M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.99M
-26.90M
-19.63M
-25.86M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.62M
1.36M
647.00K
276.00K
Interest expense
-
-
-
-
Net interest expenses
1.62M
1.36M
647.00K
276.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.22M
-27.88M
-19.94M
-25.84M
Gain or loss from assets sale
-
-
-
56.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps